163 related articles for article (PubMed ID: 24070885)
1. Assessment of serum creatinine and kidney function among incident metformin users.
Schorr M; Hemmelgarn BR; Tonelli M; Soo A; Manns BJ; Bresee LC;
Can J Diabetes; 2013 Aug; 37(4):226-230. PubMed ID: 24070885
[TBL] [Abstract][Full Text] [Related]
2. Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine.
Tuot DS; Lin F; Shlipak MG; Grubbs V; Hsu CY; Yee J; Shahinian V; Saran R; Saydah S; Williams DE; Powe NR;
Diabetes Care; 2015 Nov; 38(11):2059-67. PubMed ID: 26307607
[TBL] [Abstract][Full Text] [Related]
3. Renal function markers and metformin eligibility.
Tavares Bello C; Castro Fonseca R; Sousa Santos F; Sequeira Duarte J; Azinheira J; Vasconcelos C
Minerva Endocrinol; 2018 Sep; 43(3):246-252. PubMed ID: 28565889
[TBL] [Abstract][Full Text] [Related]
4. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic creatinine assays allow estimation of glomerular filtration rate in stages 1 and 2 chronic kidney disease using CKD-EPI equation.
Kuster N; Cristol JP; Cavalier E; Bargnoux AS; Halimi JM; Froissart M; Piéroni L; Delanaye P;
Clin Chim Acta; 2014 Jan; 428():89-95. PubMed ID: 24220551
[TBL] [Abstract][Full Text] [Related]
6. Cystatin C measurement leads to lower metformin dosage in elderly type 2 diabetic patients.
Šálek T; Adamíková A
Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):298-302. PubMed ID: 30218617
[TBL] [Abstract][Full Text] [Related]
7. The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD.
Shin JI; Sang Y; Chang AR; Dunning SC; Coresh J; Inker LA; Selvin E; Ballew SH; Grams ME
J Am Soc Nephrol; 2020 Aug; 31(8):1847-1858. PubMed ID: 32660971
[TBL] [Abstract][Full Text] [Related]
8. A Safety Comparison of Metformin vs Sulfonylurea Initiation in Patients With Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Cohort Study.
Whitlock RH; Hougen I; Komenda P; Rigatto C; Clemens KK; Tangri N
Mayo Clin Proc; 2020 Jan; 95(1):90-100. PubMed ID: 31902433
[TBL] [Abstract][Full Text] [Related]
9. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
[TBL] [Abstract][Full Text] [Related]
10. Introducing estimated glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin.
Warren RE; Strachan MW; Wild S; McKnight JA
Diabet Med; 2007 May; 24(5):494-7. PubMed ID: 17367305
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of the Korean version of CKD-EPI equation to estimate glomerular filtration rate.
Jeong TD; Lee W; Yun YM; Chun S; Song J; Min WK
Clin Biochem; 2016 Jun; 49(9):713-719. PubMed ID: 26968101
[TBL] [Abstract][Full Text] [Related]
12. Appropriateness of metformin prescription for type 2 diabetes mellitus patients with chronic kidney disease (Stages 3-5).
Ramachandran M; Loi B; Mat Ariff N; Ng OC; Zahari Sham SY; Thambiah SC; Samsudin IN
Malays J Pathol; 2020 Apr; 42(1):71-76. PubMed ID: 32342933
[TBL] [Abstract][Full Text] [Related]
13. Mortality Associated with Metformin Versus Sulfonylurea Initiation: A Cohort Study of Veterans with Diabetes and Chronic Kidney Disease.
Marcum ZA; Forsberg CW; Moore KP; de Boer IH; Smith NL; Boyko EJ; Floyd JS
J Gen Intern Med; 2018 Feb; 33(2):155-165. PubMed ID: 29181788
[TBL] [Abstract][Full Text] [Related]
14. Estimating kidney function and use of oral antidiabetic drugs in elderly.
Douros A; Ebert N; Jakob O; Martus P; Kreutz R; Schaeffner E
Fundam Clin Pharmacol; 2015 Jun; 29(3):321-8. PubMed ID: 25817734
[TBL] [Abstract][Full Text] [Related]
15. Medication safety and chronic kidney disease in older adults prescribed metformin: a cross-sectional analysis.
Huang DL; Abrass IB; Young BA
BMC Nephrol; 2014 Jun; 15():86. PubMed ID: 24906409
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of metformin in patients with chronic kidney disease stage 4 and metformin-naïve type 2 diabetes.
Dissanayake AM; Wheldon MC; Hood CJ
Pharmacol Res Perspect; 2018 Oct; 6(5):e00424. PubMed ID: 30221006
[TBL] [Abstract][Full Text] [Related]
17. Effect of prescribing metformin according to eGFR instead of serum creatinine level: A study based on Korean National Health and Nutrition Examination Survey (KNHANES) 2009-2014.
Moon SJ; Ahn CH; Cho YM
PLoS One; 2017; 12(4):e0175334. PubMed ID: 28399132
[TBL] [Abstract][Full Text] [Related]
18. Impact of routine reporting of estimated glomerular filtration rate using the CKD-EPI formula in a community population: A cross-sectional cohort study.
Mitchell T; Hadlow N; Chakera A
Nephrology (Carlton); 2014 Sep; 19(9):581-6. PubMed ID: 24888643
[TBL] [Abstract][Full Text] [Related]
19. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!
Kalantar-Zadeh K; Kovesdy CP
Diabetes Care; 2016 Jul; 39(7):1281-6. PubMed ID: 27330129
[TBL] [Abstract][Full Text] [Related]
20. The influence of pharmaceutically induced weight changes on estimates of renal function: A patient-level pooled analysis of seven randomised controlled trials of glucose lowering medication.
von Scholten BJ; Ørsted DD; Svendsen AL; Persson F; Rossing P
J Diabetes Complications; 2015; 29(8):1146-51. PubMed ID: 26345339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
